Prelude Therapeutics Incorporat

Q4 2020 13F Holders

Symbol
PRLD
CUSIP
74065P101
Type
Equity
Class
COM
Num filings
52
Total reported value, excl. options
$2.47 B
Manager Report Date Value ($000) Shares Option Type